These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11102685)

  • 1. Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design.
    Streubel A; Siepmann J; Peppas NA; Bodmeier R
    J Control Release; 2000 Dec; 69(3):455-68. PubMed ID: 11102685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous HPMCAS coatings: effects of formulation and processing parameters on drug release and mass transport mechanisms.
    Siepmann F; Siepmann J; Walther M; MacRae R; Bodmeier R
    Eur J Pharm Biopharm; 2006 Jul; 63(3):262-9. PubMed ID: 16621484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets.
    Siepmann J; Podual K; Sriwongjanya M; Peppas NA; Bodmeier R
    J Pharm Sci; 1999 Jan; 88(1):65-72. PubMed ID: 9874704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and predicting drug delivery from hydrophilic matrix tablets using the "sequential layer" model.
    Siepmann J; Streubel A; Peppas NA
    Pharm Res; 2002 Mar; 19(3):306-14. PubMed ID: 11934238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets.
    Streubel A; Siepmann J; Dashevsky A; Bodmeier R
    J Control Release; 2000 Jun; 67(1):101-10. PubMed ID: 10773333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy matrix drug delivery systems obtained by melt-processing techniques.
    Vaz CM; van Doeveren PF; Reis RL; Cunha AM
    Biomacromolecules; 2003; 4(6):1520-9. PubMed ID: 14606876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting drug release from HPMC/lactose tablets.
    Siepmann J; Karrout Y; Gehrke M; Penz FK; Siepmann F
    Int J Pharm; 2013 Jan; 441(1-2):826-34. PubMed ID: 23262427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of crystallization inhibition of HPMC and HPMCAS on model substance dissolution and release in swellable matrix tablets.
    Tajarobi F; Larsson A; Matic H; Abrahmsén-Alami S
    Eur J Pharm Biopharm; 2011 May; 78(1):125-33. PubMed ID: 21168491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blends of aqueous polymer dispersions used for pellet coating: importance of the particle size.
    Siepmann F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
    J Control Release; 2005 Jul; 105(3):226-39. PubMed ID: 15946758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of admixed carboxymethylcellulose on release of 4-aminopyridine from hydroxypropyl methylcellulose matrix tablets.
    Juárez H; Rico G; Villafuerte L
    Int J Pharm; 2001 Mar; 216(1-2):115-25. PubMed ID: 11274813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saturated phosphatidylcholine as matrix former for oral extended release dosage forms.
    Kolbina M; Bodmeier R; Körber M
    Eur J Pharm Sci; 2017 Oct; 108():86-92. PubMed ID: 28716757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
    Ebube NK; Jones AB
    Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis.
    Ferrero C; Massuelle D; Doelker E
    J Control Release; 2010 Jan; 141(2):223-33. PubMed ID: 19766681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a stable aqueous enteric coating formulation with hydroxypropyl methylcellulose acetate succinate (HPMCAS-MF) and colloidal silicon dioxide as anti-tacking agent.
    Deshpande TM; Quadir A; Obara S; Ibrahim A; Hoag SW
    Int J Pharm; 2018 May; 542(1-2):108-116. PubMed ID: 29458205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties and mechanisms of drug release from matrix tablets containing poly(ethylene oxide) and poly(acrylic acid) as release retardants.
    Zhang F; Meng F; Lubach J; Koleng J; Watson NA
    Eur J Pharm Biopharm; 2016 Aug; 105():97-105. PubMed ID: 27260202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrophilic matrices for controlled drug delivery: an improved mathematical model to predict the resulting drug release kinetics (the "sequential layer" model).
    Siepmann J; Peppas NA
    Pharm Res; 2000 Oct; 17(10):1290-8. PubMed ID: 11145237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles.
    Siepmann J; Kranz H; Peppas NA; Bodmeier R
    Int J Pharm; 2000 May; 201(2):151-64. PubMed ID: 10878322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.